a novel mechanism of action for daratumumab in myeloma
Published 5 years ago • 428 plays • Length 2:04Download video MP4
Download video MP3
Similar videos
-
3:24
novel agents for the management of r/r myeloma
-
3:00
development of novel agents, including daratumumab and carfilzomib, in myeloma
-
2:53
novel targets and dual-targeting approaches in myeloma
-
4:03
proteomics in myeloma: mass spectrometry and novel approaches
-
2:42
hdac8: a novel therapeutic target in multiple myeloma
-
2:38
how close is a cure for multiple myeloma?
-
2:49
what does the approval of darzalex faspro™ mean for myeloma patients?
-
3:41
can novel immunotherapies cure multiple myeloma?
-
1:08
novel immunotherapies for multiple myeloma & other exciting developments
-
1:04
the changing role of autosct in the treatment of multiple myeloma in the era of novel agents
-
1:19
telomerase inhibition as a novel targeted therapy for myelofibrosis
-
2:50
phase i study of abbv383, a novel bcmaxcd3 bispecific antibody, in r/r multiple myeloma
-
1:21
novel targets and the future role of combinations for myeloma
-
4:03
novel technologies in multiple myeloma and how these are changing the field
-
2:09
integrating novel agents into the treatment of multiple myeloma
-
5:07
daratumumab in the management of al amyloidosis
-
2:22
the benefit of autologous transplantation in the era of novel agents in multiple myeloma
-
2:16
the sequencing of novel therapies in myeloma (car-t, bispecifics, antibody-drug conjugates)
-
2:56
novel drugs for myeloma thromboprophylaxis
-
0:57
insights into a novel antibody-drug conjugate in myeloma: hdp-101
-
2:08
novel drug delivery method to prevent daratumumab infusion-related reactions in mm
-
0:58
minimumm-seq: a novel, minimally invasive approach to characterize myeloma pathology